Innovation
PROBALIDY: moving closer to a treatment for liver diseases
… Microbiome and Immunosurveillance Laboratory (MI2 - Univ. Paris-Saclay, Inserm) , whose Microbiome in liver diseases: from … management. PROBALIDY is currently being developed by SATT Paris-Saclay . "How can we not be interested in intestinal …Published on: Fri 12/05/2023 - 12:08